HAPILA GmbH (HAPILA) will return for the seventh successive time to the influential Chemspec Europe trade show, this time in Düsseldorf, Germany.
HAPILA has been a consistent presence at Chemspec since 2016 and will again be a prominent exhibitor at the show from Booth J50 in Hall 3 of the Messe Düsseldorf, with a display showcasing its extensive range of CDMO services, including advanced synthesis and API development.
The stand will also represent the work of HAPILA’s strategic marketing and sales partner Transo-Pharm Handels-GmbH, based in Siek near Hamburg, Germany.
The HAPILA team in Düsseldorf will be led by CEO Dr. Uwe Müller. They will emphasize HAPILA’s distinctive identity as both a CDMO as well as CEP-holder of its own API.
